Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis

OBJECTIVE: To assess the safety of adalimumab in global clinical trials and postmarketing surveillance among patients with rheumatoid arthritis (RA). METHODS: Safety data for adalimumab treated patients from randomised controlled trials, open label extensions, and two phase IIIb open label trials we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schiff, M H, Burmester, G R, Kent, J D, Pangan, A L, Kupper, H, Fitzpatrick, S B, Donovan, C
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Group 2006
Schlagworte:
Extended Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798196/
https://ncbi.nlm.nih.gov/pubmed/16439435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.043166
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge